Trustees. Annual Report for the period
Peri￿1 start date
Pericrtj end date
From
To
Section A
Reference and administration details
Charfty name
Liver4Life
Other names charity Is known by
R•g16tered charlty numbor (If any)
1152618
Charlty's prlnclpal address
Holme Cottage
Croft Road
Neacroft
Postcode
BH23 8JS
Nam08 of tho charlty trustees who manage th• ¢harlty
Dat•• •¢t•d 11 notlor ¥thol•
Olllc•111 any)
ar
N•m• 01 p•r￿tt lor body) •ntitl•d
toa
Int tru8t••
If an
Tru8t•• n•m•
Richard Aspinall
Sheila Connolly
Elizabeth Wilson
Alan Williams
Chairperson
10
12
13
14
15
16
17
18
19
20
Names of the trustees for the charlty. If any, Ifor example. any custodlan trusteos)
Name
Dates acted If not for whole
ear
TAR
Marth 2012

The ¢haTIty trustees confim Ihat they hav8 had regard to the guidance
issued by Ihg Charity C<)mmi66ion on public benefit. and havo followed
Ihis in planning and undertaking our activities.
The tharity's aims are to support people affected by INer conditions
through the provision of a variety of activities. The main activities
undertaken in relation to our objects are:
Continued delivery of'optimising Hep C Support. campaign to raise
avrdreness of HCV and to offer inforrnation about associated risks via the
medium of regional training sessions aimed at both people affected by
HCV and those who engage with this community.
Continued delivery of Auttrimmune condition support groups to
enable both peers. carers and mentors to develop a better understsnding
of aut&lmmune liver conditions and to build closer links within their
communities
Signpostsng other chanties, helplng organlsations and groups which
support the needs of service us8ts.
Ongoing development of a helpline and website to all￿ people
affected by liver I￿)ndItiOnS to access relevant inf0m￿tIOn
Helpline available 5 days per week with specialist advice and
signpostlng
6. Van work contlnued. and the van was used for outreach and
community SUPPOrt during COVID uisis, we also stsrted Y￿rkIng wlth
University Hospital tk)rset for outreath to smaller more rural
communili8s, indudir¥J FibroscanniTrJ
Summary of th• maln
actlvltles und•rtak•n for th•
publ1¢ bonoflt In relatlon to
thoso objocts (Includè wfthln
thls s•ctlon the 8tatutory
dgclaratlon that trustses hav•
had rogard to the guldanc•
Issued by the Charlty
Comml•8lon on publlc
b•noflt)
You may choo•• to include
further statements, where
relevant, about:
pollcy on grantmaklng.
policy programme related
investment;
contribution made by
volunteers.
March 2012
TAR

Section D
Achievements and performance
Liver4Life {L4L), which set its initial goals as providing a free-phone
helpline and developing infomiation to help the recently diagnosed and
those affected by liver Conditions has continued to grow and develop.
Continue to support 4 patient support groups
The L4L van was a valuable asset in reaching communities during the
continued lockdowns. We used the van to support palients who were
vulnerable and shielding. Working with UHD to provide outreach into
small8r rural communities. and we are planning outreach to homeless
and at risk groups a¢ross the South of England.
L4L did not attend any conferences this year. We are also working hard
to build our social media profile.
The managément team continue to create a strong brand and excellent
aWa￿neSS to ensure L4L is identified as 8 very successful national liver
charity- Clear goals and tsrgets have been developed jointly with the
trustees and the management t8am. and with the implementation of
these slrategies. L4L will Gonts'nue to grow and continue to be a key
influencer with the liver community.
The charitses work was undennined again this year with COVID, but
continued to deliver on all services including the helpline and patient
support groups.
Summary of thè maln
achievements of the charlty
durlng the year
Marth 2012
TAR

Section E
Financial review
The Trustees of Liver4Lrfe belleve that the Gharity should hold financial
reseNes (the 'Emergency Operating Reserve. . EOR) because
i. il has no endo%vni8nt fundlng and is entirely dèpendent for
income upon donor funding from year to year which is inevitably
subject to fluctuation and
ii. it requires protection against. and the ability to continue operating
despite, catsstrophic or lesser but damaging events
The trustees believe that the minimum level of the EOR Should be the
equivalent of six months. operab'ng costs calculated and reviewed
annually and believe that the EOR should be built up to the desired level
in stages consistent wth charty's overall financial position and Its
need to maintain and devel
its charitable activities.
Brlaf statsmont of the
¢harlty'8 policy on re8erv•8
D•tall8 of any lunds matsrlalty
In deflclt
NIA
Furthor flnanclal rnvlew d•lalls (Optlonal Informatlon)
You may Ghoo•• to Include
additional infomiation. where
relevant about..
the charity's principal
sources of funds (including
any fundraislng):
how expenditure has
supported th8 kay obJ8Ctlves
of the charity:
Investrnent pollcy and
obJectlv88 includlng any
ethical investment pollcy
adopted.
Section F
Other optional information
M8fL* 2012

Section G
Declaration
The trustees declare that they have approved the trustees, report above.
Signed on behalf of the charlty's truslees
Slgnature{s)
A'l
Alan
liams
Full name(s)
Posltlon (eg Secretary, Chalr,
ètc)
ard
pir￿11
Chair of Tnjstees
Trustee
Dato
Mar¢h 2012
TAR

||**Liver4Life**|**Liver4Life**|**Liver4Life**|**1152618**|**CC16a**|
|---|---|---|---|---|---|
||**Receipts andpayments accounts**|||||
||**For the period**<br>**from**|**01/04/2021**|**To**|**31/03/2022**||
|||||||
|**Section A Receipts and payments**||||||
|**A1 Receipts**|**Unrestricted**<br>**funds**<br>**to the nearest**<br>**£**|**Restricted**<br>**funds**<br>**to the nearest £**|**Endowment**<br>**funds**<br>**to the nearest £**|**Total funds**<br>**to the nearest £**|**Last year**<br>**to the nearest £**|
|<br>Income|**16,445**|**-**|**-**|**16,445**|**41,370**|
|Friends of Liver Lifeline|**-**|**2**|**-**|**2**|**1,579**|
||**-**|**-**|**-**|**-**|**-**|
||**-**|**-**|**-**|**-**|**-**|
||**-**|**-**|**-**|**-**|**-**|
||**-**|**-**|**-**|**-**|**-**|
||**-**|**-**|**-**|**-**|**-**|
||**-**|**-**|**-**|**-**|**-**|
|**_Sub total_**_(Gross income for AR)_|**16,445**|**2**|**-**|**16,447**|**42,949**|
|||||||
|**A2 Asset and investment sales,**<br>**(see table).**||||||
||**-**|**-**|**-**|**-**||
||**-**|**-**|**-**|**-**|**-**|
|**_Sub total_**|**-**|**-**|**-**|**-**|**-**|
|**_Total receipts_**<br>**A3 Payments**||||||
||**16,445**|**2**|**-**|**16,447**|**42,949**|
|||||||
|<br>Not2Sexy- Project|**-**|**-**|**-**|**-**|**-**|
|Office Equipment/Stationery|**348**|**-**|**-**|**348**|**947**|
|Van and Travel Expenses|**2,251**|**1,879**|**-**|**4,130**|**4,796**|
|Patient Support|**3,886**|**-**|**-**|**3,886**|**2,686**|
|Membership|**-**|**-**|**-**|**-**|**-**|
|I'm Worth It|**-**|**-**|**-**|**-**|**-**|
|Helpline|**12,055**|**-**|**-**|**12,055**|**5,194**|
|OptimisingHepC Support - Project|**-**|**-**|**-**|**-**|**3,683**|
|Fibroscan|**1,050**|**-**|**-**|**1,050**|**-**|
|Fundraising|**429**|**-**|**-**|**429**|**-**|
|**_Sub total_ **|**20,019**|**1,879**|**-**|**21,898**|**17,306**|
|||||||
|**A4 Asset and investment**<br>**purchases, (see table)**||||||
|Medical Equipment|**-**|**-**|**-**|**-**|**-**|
|TestingVan|**-**|**-**|**-**|**-**|**10,400**|
|**_Sub total_ **|**-**|**-**|**-**|**-**|**10,400**|
|**_Total payments_**<br>**_Net of receipts/(payments)_**<br>**A5 Transfers between funds**<br>**A6 Cash funds last year end**<br>**_Cash funds this year end_**||||||
||**20,019**|**1,879**|**-**|**21,898**|**27,706**|
|||||||
||**-                3,574**|**-               1,877**|**-**|**-                5,451**|**15,243**|
||**-**|**-**|**-**|**-**|**-**|
||**10,475**|**2,123**|**-**|**12,598**|**10,475**|
||**6,901**|**246**|**-**|**7,147**|**25,718**|



CCXX R1 accounts (SS) 

31/01/2023 

1 



## **Section B Statement of assets and liabilities at the end of the period** 

|**Categories**<br>Signed by one or two trustees on<br>behalf of all the trustees<br>**B5 Liabilities**<br>**B3 Investment assets**<br>**B2 Other monetary assets**<br>**B4 Assets retained for the**<br>**charity’s own use**<br>**B1 Cash funds**|**Details**|**Unrestricted**<br>**funds**<br>**to nearest £**|**Restricted**<br>**funds**<br>**to nearest £**|**Endowment**<br>**funds**<br>**to nearest £**|
|---|---|---|---|---|
||Bank Accounts|**6,895**|**-**|**-**|
||CAF Cash|**-**|**-**|**-**|
||HCPC|**-**|**-**|**-**|
||CAF Gold - FOLL|**-**|**246**|**-**|
||**_Total cash funds_**|**6,895**|**246**|**-**|
||(agree balances with receipts and payments<br>account(s))<br>**Details**|Agreement Error|OK|OK|
|||**Unrestricted**<br>**to nearest £**|**Restricted**<br>**to nearest £**|**Endowment**<br>**to nearest £**|
|||**-**|**-**|**-**|
|||**-**|**-**|**-**|
|||**-**|**-**|**-**|
|||**-**|**-**|**-**|
|||**-**|**-**|**-**|
|||**-**|**-**|**-**|
|||**Fund to which asset**<br>**belongs**|**Cost (optional)**|**Current value**<br>**(optional)**|
||**Details**||||
||||**-**|**-**|
||||**-**|**-**|
||||**-**|**-**|
||||**-**|**-**|
||||**-**|**-**|
|||**Fund to which asset**<br>**belongs**|**Cost (optional)**|**Current value**<br>**(optional)**|
||**Details**||||
||||**-**|**-**|
||||**-**|**-**|
||||**-**|**-**|
||||**-**|**-**|
||||**-**|**-**|
||||**-**|**-**|
||||**-**|**-**|
||||**-**|**-**|
||||**-**|**-**|
|||**Fund to which**<br>~~**liabilitrelates**~~|**Amount due**<br>~~**(otional)**~~|**When due**<br>~~**(otional)**~~|
||**Details**||||
|||~~**y **~~|~~**p**~~<br>**-**|~~**p**~~|
||||**-**||
||||**-**||
||||**-**||
||||**-**||
||Signature||||
|||||Date of<br>approval|
||||||



CCXX R2 accounts (SS) 

31/01/2023 

2